Extends the patent for the drug Ansaid for 24 months.
Subcommittee Hearings Held.
Introduced in Senate
Read twice and referred to the Committee on Judiciary.
Referred to Subcommittee on Patents, Copyrights and Trademarks.
Subcommittee on Patents, Copyrights and Trademarks. Hearings held. Hearings printed: S.Hrg. 102-824.
Subcommittee on Patents, Copyrights and Trademarks. Approved for full committee consideration with an amendment in the nature of a substitute favorably.
Committee on Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Committee on Judiciary. Reported to Senate by Senator Biden with an amendment in the nature of a substitute and an amendment to the title. With written report No. 102-414.
Committee on Judiciary. Reported to Senate by Senator Biden with an amendment in the nature of a substitute and an amendment to the title. With written report No. 102-414.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 695.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line